CARDINAL HEALTH, INC. |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 99.27 USD | +1.60% |
|
+2.99% | -1.52% |
Financials (USD)
| Sales 2024 * | 226B | Sales 2025 * | 210B | Capitalization | 24.18B |
|---|---|---|---|---|---|
| Net income 2024 * | 955M | Net income 2025 * | 1.44B | EV / Sales 2024 * | 0.11 x |
| Net Debt 2024 * | 732M | Net Debt 2025 * | 1.2B | EV / Sales 2025 * | 0.12 x |
| P/E ratio 2024 * |
25.2
x | P/E ratio 2025 * |
16
x | Employees | 47,520 |
| Yield 2024 * |
2.03% | Yield 2025 * |
2.05% | Free-Float | 74.15% |
More Fundamentals
* Assessed data
More news
Latest transcript on Cardinal Health, Inc.
More recommendations
More press releases
| 1 day | +1.60% | ||
| 1 week | +2.99% | ||
| 1 month | -2.84% | ||
| 3 months | -12.44% | ||
| 6 months | -7.36% | ||
| Current year | -1.52% |
1 week
94.04
99.44
1 month
94.04102.26
Current year
94.04116.04
1 year
83.07116.04
3 years
45.85116.04
5 years
39.05116.04
10 years
39.05116.04
| Managers | Title | Age | Since |
|---|---|---|---|
Jason Hollar
CEO | Chief Executive Officer | 51 | 20-04-26 |
Aaron Alt
DFI | Director of Finance/CFO | 53 | 23-02-09 |
Michelle Greene
CTO | Chief Tech/Sci/R&D Officer | 54 | 20-12-31 |
| Members of the board | Title | Age | Since |
|---|---|---|---|
| Director/Board Member | 55 | 22-09-05 | |
| Director/Board Member | 71 | 13-09-11 | |
Gregory Kenny
CHM | Chairman | 71 | 06-12-31 |
| Date | Price | Change | Volume |
|---|---|---|---|
| 24-05-31 | 99.27 | +1.60% | 4,182,760 |
| 24-05-30 | 97.71 | +1.63% | 2,153,325 |
| 24-05-29 | 96.14 | +1.47% | 1,721,760 |
| 24-05-28 | 94.75 | -1.70% | 1,782,945 |
| 24-05-24 | 96.39 | +0.35% | 1,206,966 |
Delayed Quote Nyse, May 31, 2024 at 04:00 pm EDT
More quotes
Cardinal Health, Inc. is specialized in the distribution of products and health services to pharmacies, hospitals and medical practices. Net sales break down by activity as follows:
- distribution of pharmaceutical products (92.7%);
- distribution of medical, surgical and laboratory products (7.3%). The group also develops a manufacturing of medical and surgical products activity (masks, overalls, gloves, diagnostic products, products of aspiration and collection of liquids, radiology intervention, respiratory assistance, etc.).
The United States accounts for 97.7% of net sales.
Sector
Pharmaceuticals
Calendar
2024-06-30
- Ex-dividend day
Related indices
Trading Rating
Investor Rating
ESG Refinitiv
C+
Sell
Buy
Mean consensus
OUTPERFORM
Number of Analysts
16
Last Close Price
99.27
USD
Average target price
111.9
USD
Spread / Average Target
+12.68%
EPS Revisions
| 1st Jan change | Capi. | |
|---|---|---|
| -1.52% | 24.18B | |
| +23.03% | 74.04B | |
| +3.67% | 8.46B | |
| +8.55% | 8.34B | |
| -23.71% | 7.64B | |
| +15.20% | 5.33B | |
| +2.68% | 4.12B | |
| -6.90% | 3.92B | |
| +5.56% | 3.89B | |
| +18.80% | 3.54B |
- Stock Market
- Equities
- CAH Stock
